Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum

November 11, 2009 8:00 AM EST

UNION CITY, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Brenton Hanlon, Vice President, North American Medical Sales and Marketing, will present at the Sidoti & Company Second Annual New York Institutional Investor Forum on Friday, November 20, 2009 at 4:00 p.m. Eastern. The conference will be held at The Grand Hyatt Hotel in New York City.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

    Contact:  Clint Severson              Lytham Partners, LLC
              Chief Executive Officer     Joe Dorame, Joe Diaz & Robert Blum
              ABAXIS, Inc.                602-889-9700
              510-675-6500

SOURCE Abaxis, Inc.


Related Categories

Press Releases

Stocks Mentioned

ABAX 23.78

+0.43 +1.84%
Volume: 164,258
Track ABAX


Related Entities


Add Your Comment